Potency of Hyperbaric Oxygen Therapy on Oral Candidiasis Diabetes Mellitus.

OBJECTIVES

This study aimed to determine the potency of hyperbaric oxygen therapy (HBOT) to the blood glucose level, amount of lymphocytes, and the expression of antibody anti- in oral candidiasis diabetes mellitus.

MATERIALS AND METHODS

Thirty Wistar rats were divided into five groups: K1 normal-control group, while K2, P1, P2, and P3 were diabetes induced by streptozotocin 50 mg/kg body weight. Oral candidiasis was induced by inoculation 0.1 mL ATCC 10321 on dorsum of the tongue. P1 was given nystatin oral suspension, P2 was treated by HBOT 2.4 ATA, 3 × 30 minutes each with a 5-minute interval, and P3 was treated by the combination of nystatin and HBOT. All the treatments were performed for 5 consecutive days. Fasting blood glucose level was examined on glucometer strips, lymphocyte was examined from complete blood count, and the expression of antibody anti- was examined on immunohistochemistry staining STATISTICAL ANALYSIS:  Data analyzed by a one-way analysis of variance and least significant difference test with the result of -value less than 0.05 was considered to be statistically significant.

RESULTS

HBOT reduced blood glucose level ( > 0.05) increased the amount of lymphocyte ( < 0.05). All treatments reduced the expression of antibody anti- ( < 0.05) with the best result on combination of HBOT with nystatin.

CONCLUSION

HBOT decreased the blood glucose level, increased the amount of lymphocytes, and reduced the expression of antibody anti- in oral candidiasis diabetes mellitus.